In the post-genomic era, the expression and investigation of human (auto)im
munity genes seems more relevant than ever. The generation of humanized ani
mal models of human diseases will be useful to study the interplay between
genetic and nongenetic factors in disease development and may form a basis
for the development of new drugs that act more specifically than the ones c
urrently in use. Transgenic mice have been generated that express various h
uman proteins - candidate autoantigens, disease-associated MHC class II mol
ecules, TCRs and/or CD4 - in order to study diseases such as rheumatoid art
hritis, multiple sclerosis and diabetes.